Anti-Human TNFRSF25 Recombinant Antibody (11H08_H1) (CAT#: TAB-246MZ)

This antibody that specifically binds to DR3 receptors has uses in the prevention, detection, diagnosis, treatment or amelioration of a disease or disorder, especially inflammatory and autoimmune diseases, such as Crohn's disease, Inflammatory Bowel Disease, Multiple Sclerosis.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
FC

Figure 1 Flow cytometry results of 11H08 binding to hDR3-expressing HEK293F cells.

Figure 1 Flow cytometry results of 11H08 binding to hDR3-expressing HEK293F cells.

Agonist

Figuge 2 Agonist activity of the whole 11H08 antibody.

Figuge 2 Agonist activity of the whole 11H08 antibody.

TF1 cells were treated with media and cycloheximide along with varying concentrations of the whole 11H08 immunoglobulin or 10 ng/mL of the positive control hTL1A protein, as indicated. This was compared with cells treated only with media and cycloheximide. Full length anti-DR3 antibodies act as TL1A agonists and induce cell death.

Block

Figure 3 11H08-Fab molecules block TL1A-induced cell death.

Figure 3 11H08-Fab molecules block TL1A-induced cell death.

TF-1 cells were treated with 10 ng/mL hTL1A and cycloheximide, along with varying concentrations of the anti-DR3 Fab molecules H1L2-Fab, H5L2-Fab and 11H08-Fab, as indicated. As shown by the graph, H1L2-Fab, H5L2-Fab and 11H08-Fab inhibited TL1A-induced apoptosis in human TF-1 cells, showing a dose-dependent prevention of apoptosis in cycloheximide-treated TF-1 cells in the presence of TL1A.

FuncS

Figure 4 Anti-DR3 Fab-HSA molecules block TL1A-induced cytokine release.

Figure 4 Anti-DR3 Fab-HSA molecules block TL1A-induced cytokine release.


Specifications

  • Host Species
  • Human
  • Type
  • Humanized antibody
  • Specificity
  • Human
  • Clone
  • 11H08_H1
  • Applications
  • Agonist, Block, FC, FuncS
  • Related Disease
  • Crohn's disease, colitis, Inflammatory Bowel Disease, arthritis, asthma, Multiple Sclerosis, atherosclerosis, and allergic disorders

Applications

  • Application Notes
  • This antibody has been reported for use in Agonist, Blocking, Flow Cytotoxicityometry, Functional Assay.

Target

  • Alternative Names
  • TNFRSF25; tumor necrosis factor receptor superfamily, member 25; DR3; TR3; DDR3; LARD; APO-3; TRAMP; WSL-1; WSL-LR; TNFRSF12; tumor necrosis factor receptor superfamily member 25; protein WSL-1; death receptor beta; apoptosis inducing receptor; apoptosis-inducing receptor AIR; apoptosis-mediating receptor DR3; apoptosis-mediating receptor TRAMP; death domain receptor 3 soluble form; lymphocyte-associated receptor of death; tumor necrosis factor receptor superfamily, member 12 (translocating chain-association membrane protein)

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone 11H08_H1"

See other products for "TNFRSF25"

Recombinant Antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAB-246MZ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare